Sun Pharmaceutical Industries Q2 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,713.80
-16.35 (-0.95%)
-16.35 (-0.95%)Volume33.92 K
Updated: Tue 20 May, 2025 | 15:29:45
NSE
1,707.80-22.40 (-1.29%)
-22.40 (-1.29%)Volume2.71 M
Updated: Tue 20 May, 2025 | 15:52:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Sun Pharmaceutical Industries Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 13,291.39 | 12,652.75 | 5.05% | 13,291.39 | N/A |
| Selling/ General/ Admin Expenses Total | 2,477.70 | 2,454.62 | 0.94% | 2,477.70 | N/A |
| Depreciation/ Amortization | 625.91 | 655.13 | -4.46% | 625.91 | N/A |
| Other Operating Expenses Total | 4,308.62 | 3,864.63 | 11.49% | 4,308.62 | N/A |
| Total Operating Expense | 10,106.43 | 9,649.81 | 4.73% | 10,106.43 | N/A |
| Operating Income | 3,184.96 | 3,002.94 | 6.06% | 3,184.96 | N/A |
| Net Income Before Taxes | 3,597.88 | 3,423.50 | 5.09% | 3,597.88 | N/A |
| Net Income | 3,040.16 | 2,835.62 | 7.21% | 3,040.16 | N/A |
| Diluted Normalized EPS | 12.70 | 11.80 | 7.63% | 12.70 | N/A |